Jeffrey Hackman - Sep 27, 2023 Form 4 Insider Report for Comera Life Sciences Holdings, Inc. (CMRA)

Role
Chairman, President, and Chief Executive Officer., Director
Signature
/s/ Ryan M. Rourke Reed, Attorney-in-Fact
Stock symbol
CMRA
Transactions as of
Sep 27, 2023
Transactions value $
$0
Form type
4
Date filed
9/28/2023, 04:06 PM
Previous filing
Feb 16, 2023
Next filing
Aug 19, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CMRA Stock Option (Right to Purchase) Award $0 +600K $0.00 600K Sep 27, 2023 Common Stock 600K $0.38 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the stock option vest on September 27, 2024, with the remaining shares vesting on a monthly basis on the 27th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on September 27, 2027.

Remarks:

Chairman, President, and Chief Executive Officer.